| INTRODUCTION
Inflammatory bowel diseases (IBD) comprising Crohn's disease (CD) and ulcerative colitis (UC) are chronic relapsing-remitting inflammatory diseases of the gastrointestinal tract affecting individuals worldwide. The prevalence of CD and UC is highest in Western Europe and North America. However, rising incidence has been noted globally, particularly in newly industrialized regions such as Asia, where IBD was previously considered rare. [1] [2] [3] The exact cause of IBD remains incompletely understood. However, the working hypothesis is that these diseases arise due to a confluence of genetic susceptibility, environmental exposures and a dysregulated immune response to dysbiotic intestinal microbiota. 4, 5 The recognition of a central role of the intestinal microbiome in the pathogenesis of IBD has renewed focus on environmental exposures that may modify the composition and function of the microbiome. 6, 7 While gut microbial composition and function are susceptible to disruption throughout life, it has been elegantly established that the microbiome is most unstable and sensitive to external environmental exposures in early infancy. 8, 9 Consequently, factors that contribute to perturbation of the microbiome in early life may have strong effects on the development of diseases like IBD.
Breast milk is one of the earliest environmental factors an infant is exposed to. Prior studies have demonstrated that breastfeeding may influence development of immune-mediated diseases through several mechanisms including promotion of oral tolerance, prevention of infections in infancy, maintaining epithelial barrier integrity, as well as direct immunologic effects. [10] [11] [12] [13] Breastfeeding exerts a strong influence on intestinal microbial composition, leading to higher abundances of firmicutes and actinobacteria when compared to formula fed infants. [14] [15] [16] [17] [18] Furthermore, formula fed infants have a greater abundance of peptostreptococci including Clostridia, which are associated with allergic sensitisation and atopic responses. [14] [15] [16] [17] Previous studies have suggested that breastfeeding in infancy is associated with reduced risk of rheumatoid arthritis, although data for other immune-mediated conditions like coeliac disease and type 1 diabetes, are less persuasive. [19] [20] [21] Two prior meta-analyses suggested a modest inverse association between breastfeeding and risk of IBD. 22, 23 However, these analyses had a number of limitations, including restriction to paediatric onset disease, lack of stratification by duration of breastfeeding, and failure to assess for risk modification by geography or ethnicity. Consequently, a more nuanced examination of the relationship between breastfeeding status and risk of IBD is essential to robustly define this association.
We performed this meta-analysis with the following aims: (1) to examine the association between breastfeeding status in infancy and risk of CD and UC; (2) to define the impact of duration of breastfeeding and risk of IBD and (3) to determine whether ethnicity and geography modifies the association between breastfeeding and IBD.
2 | METHODS
| Data sources and study selection
A systematic electronic search was performed using the Medline/ PubMed and Embase databases from inception till November 2016
with the following combination of search terms: "Crohn's disease" or "Ulcerative Colitis" or "Inflammatory Bowel Disease" and "breastfeeding" or "breastfeeding" or "breast feeding" or "breastfed" or "breast milk" or "perinatal" or "infant feeding" or "early life" or "environmental risk factors". We restricted our search to studies available as full text, in the English language, and encompassing paediatric and/or adult-onset IBD. Manual searches of bibliographies of retrieved articles and relevant reviews were subsequently performed to identify additional relevant articles. Titles and abstracts of all identified articles were examined by two members of the study team (LX, AA) to determine relevance of the studies. Potentially relevant studies were retrieved for review of the full manuscript. Disagreements were resolved through consensus.
To be eligible for inclusion, the study needed to provide total numbers of patients with CD, UC, or all IBD cases, describe exposure to any breastfeeding in infancy in the cases and controls, and either report unadjusted to adjusted odds ratios (OR), relative risk or hazard ratios for association or provide sufficient raw data for them to be calculable. Studies were excluded if there was no control group, the total number of included participants was not provided, or if it was not possible to calculate ORs and confidence intervals (CIs). Authors of included studies were contacted when necessary to obtain additional data not available in the published work. Breastfeeding of any type (exclusive or partial) or duration was eligible for inclusion.
| Data extraction
From each eligible study, one of the study investigators extracted data on primary author, study period, study design, country of origin, predominant race or ethnicity of the study population, mean or median age at IBD diagnosis, IBD type (CD, UC or all IBD), and number of cases and controls. Studies were extracted into a Microsoft Excel database. Ethnicity of the study population was determined as the predominant ethnic group if explicitly provided in the study, or as the demographically major ethnic group in the country or region of the study. In addition to overall proportion in each group reporting a history of being breastfed in infancy, we also retrieved data on whether the breastfeeding was exclusive or partial. We assessed effect of duration of breastfeeding in infancy, calculating stratum specific OR for breastfeeding >3, >6, and > 12 months. The reference group in most studies comprised of those who were never breastfed while for some studies the control group could have included patients who were breastfed for a duration shorter than the stratum of interest (for example, breastfed >6 months compared to those breastfed 0-5 months). We used maximally adjusted ORs estimates. Pre-specified stratified analyses were performed by time of onset of IBD (adult or paediatric-onset), ethnicity and geography (Caucasian, Asian or Hispanic), and by duration of breastfeeding (>3, >6 or >12 months). Statistical differences between subgroups was estimated using the t-test. The Cochrane i 2 statistic was used to calculate the heterogeneity between the studies with an i 2 > 50% or P < .10 indicating significant heterogeneity. We assessed for publication bias using the Begg's and Egger's tests and visual inspection of the funnel plot. Meta-regression was performed based on method of assessment of breastfeeding exposure, number of included patients, year of publication, region of study, frequency of breastfeeding among controls, the median age of diagnosis of IBD and paediatric compared to adult onset disease.
3 | RESULTS (Table 1, Table S1 ). Most studies (n = 33) were case control by design and only 2 were prospective cohorts. A history of breastfeeding in infancy was ascertained by a questionnaire in most studies 
| Included studies

| Breastfeeding and risk of CD and UC
We first analysed pooled data from all studies utilising a history of being breastfed as a dichotomous variable. Compared to those who were never breastfed, a history of ever being breastfed was associated with a significantly lower risk of IBD (OR 0.74, 95% CI 0.66-0.83) (P < .001) with significant heterogeneity between studies (i 2 = 72%, P < .001; Figure S1 ). 
| Effect of ethnicity
Interesting differences were observed when stratifying by ethnicity. Figure S4 ). Figure S5 ). In CD, for each duration stratum, the magnitude of the protective association was significantly larger in Asian compared to Caucasian populations. In UC, this was observed only for breastfeeding duration of at least 12 months (data not shown).
| Duration of breastfeeding
| Meta-regression, publication bias and study quality
The quality of the included studies ranged from 3 to 9 according to the NOS (median 6) (Table S2 ). There was no evidence for publication bias using the Egger's (P = .27) or Begg's tests (P = .15; Figure S6) . Meta-regression revealed that ethnicity and number of cases influenced the pooled effect sizes (Table S3 ). The reduction in risk with breastfeeding was more striking in studies with fewer than 100 cases (OR 0.52 and 0.57 respectively for CD and UC) compared to larger studies (OR 0.80 and 0.87), though statistically significant associations were noted for both categories of study size. [62] [63] [64] Consequently, modification of such factors may offer the greatest potential for primary prevention of these complex and disabling diseases. In this systematic review and meta-analysis, we demonstrate a strong inverse association between breastfeeding in infancy and development of paediatric and adult-onset IBD. We also demonstrate a dose-response effect with the greatest benefit being observed with breastfeeding for at least 12 months. Our findings highlight the significant additional benefit of breastfeeding beyond providing nutrition and protection against infections for the newborn.
| DISCUSSION
Breastfeeding in infancy may reduce the risk of developing CD or UC through several mechanisms. Our findings are consistent with prior studies demonstrating a similar protective association between a history of being breastfed in infancy and development of CD and UC. 22, 23 However, two additional important observations in our results are a demonstration of a dose-response effect and the impact of ethnicity and geography.
While the pooled ORs demonstrate that breastfeeding for even 3 months is protective compared to never being breastfed, breastfeeding for 12 months or longer has an even greater magnitude of effect (pooled OR 0.20-0.21). Indeed, the magnitude of this association is even stronger than other protective factors such as appendectomy in UC. 73 A second interesting observation is that the magnitude of association was greater in Asian population compared Ecologically as well several pieces of evidence support a link between lack of breastfeeding and risk of IBD. Globally, rates of exclusive breastfeeding for 12 months duration are lowest in highincome countries, which also have higher incidences of IBD. 61 Asian countries still have one of the lowest IBD incidence and prevalence rates in the world currently, in contrast to that in Western Europe, North America, or Australia and New Zealand. Within Asia, the rates of breastfeeding are higher in Indonesia and the Philippines, whereas rates in China and Taiwan are low. 78 These variations in breastfeeding, coincidentally, also reflect the local IBD prevalence of these countries. 3 The temporal decline in rates of breastfeeding after World War II 79 coincides with the rise of IBD in the subsequent decades. 1 In 1922, 90% of infants in USA were estimated to have been breastfed to 12 months, while in the 1960s prevalence of breastfeeding on discharge from hospital were estimated to be only 18%. 79 We readily acknowledge several limitations to our meta-analysis.
First, there was considerable heterogeneity between the included studies. Reasons for this could be differing study qualities, ethnicities and age groups of study populations, differences in control popula- 
